Results 71 to 80 of about 512,437 (358)

Focal Spot, Fall/Winter 1994 [PDF]

open access: yes, 1994
https://digitalcommons.wustl.edu/focal_spot_archives/1068/thumbnail ...

core   +1 more source

Advances and future of Radiation Oncology [PDF]

open access: yesReports of Practical Oncology & Radiotherapy, 2013
Review of recent advances and vision for future developments in clinical practice of Radiation Oncology.There have been substantial research and technological developments in Radiation Oncology over the past 40 years.The relevant literature was reviewed and the authors offer their perspective on future opportunities for advancement in Radiation ...
Sasa Mutic, Carlos A. Perez
openaire   +3 more sources

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner   +6 more
wiley   +1 more source

Focal Spot, Fall 1984 [PDF]

open access: yes, 1984
https://digitalcommons.wustl.edu/focal_spot_archives/1038/thumbnail ...

core   +1 more source

Dosimetric Performance and Planning/Delivery Efficiency of a Dual-Layer Stacked and Staggered MLC on Treating Multiple Small Targets: A Planning Study Based on Single-Isocenter Multi-Target Stereotactic Radiosurgery (SRS) to Brain Metastases. [PDF]

open access: yes, 2019
Purpose: To evaluate the dosimetric performance and planning/delivery efficiency of a dual-layer MLC system for treating multiple brain metastases with a single isocenter.
Alonso-Basanta, Michelle   +8 more
core   +2 more sources

Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual Meeting

open access: yesAdvances in Radiation Oncology, 2020
Diversifying the radiation oncology workforce is an urgent and unmet need. During the American Society of Radiation Oncology (ASTRO) 2019 Annual Meeting, ASTRO's Committee on Health Equity, Diversity, and Inclusion (CHEDI) and the National Cancer ...
Gita Suneja, MD, MSHP   +10 more
doaj  

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

open access: yesMolecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon   +13 more
wiley   +1 more source

Intensity-modulated stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning. [PDF]

open access: yes, 2014
BackgroundStereotactic Radiosurgery (SRS) is a common tool used to treat Arteriovenous Malformations (AVMs) in anatomical locations associated with a risk of surgical complications.
Gete, Ermias   +5 more
core   +3 more sources

WeWhoCurie: An Initiative to Advocate for Those Underrepresented in Radiation Oncology

open access: yesAdvances in Radiation Oncology, 2023
Purpose: An initiative to advocate for those underrepresented in radiation oncology. Methods and Materials: Inspired by the success of the #ILookLikeAnEngineer and #ILookLikeASurgeon campaigns, this initiative aimed to break down stereotypes in ...
Joy Ogunmuyiwa, MD, MPH   +9 more
doaj  

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

open access: yesMolecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy